APLT News and Press, Applied Therapeutics Inc. From 01/21/20

NEW YORK, Jan. 21, 2020 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ: APLT) (the “Company”), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today...

Applied Therapeutics, Inc. ( APLT ) increased 34% to $35.18 on Wednesday after announcing positive topline results from the Phase 2 portion of its ACTION-Galactosemia study of AT-007 for adult Galactosemia patients. The data was so compelling according to the company that it plans to apply f...

Shares of Applied Therapeutics (NASDAQ: APLT) are up 29% at 12:38 p.m. EST after the biotech reported positive data from a phase 2 clinical trial of AT-007 in galactosemia patients. People with galactosemia can't properly process a sugar called galactose, which is found in food and also mad...

Gainers: ShiftPixy (NASDAQ: PIXY ) +162% . More news on: ShiftPixy, Inc., Wah Fu Education Group Limited, Verastem, Inc., Stocks on the move, Read more ...

ShiftPixy (NASDAQ: PIXY ) +199%  on completing recapitalization . More news on: ShiftPixy, Inc., Applied Therapeutics, Inc., Mechel PAO, Stocks on the move, Read more ...

Thinly traded micro cap Applied Therapeutics (NASDAQ: APLT ) is up  21%  premarket on average volume in reaction to positive results from a Phase 2 clinical trial, ACTION-Galactosemia , evaluating candidate AT-007 in adult patients with galactosemia , a rare inherited metabol...

AT-007 demonstrated a robust and sustained reduction in galactitol vs placebo; significant plasma galactitol reduction of ~50% (p<0.01) AT-007 was well-tolerated; no drug-related adverse events reported at any dose to date Applied Therapeutics expects to file for regulatory appr...

Investing in IPO stocks  can be fun, but also risky. There can be a scarcity of information about a brand new equity. And sometimes the underwriters intentionally lowball the value of a company, in order to hype the stock (and reward the bank's clients who bought shares on the cheap). None...

NEW YORK, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics Inc. (Nasdaq:APLT), announced today that Shoshana Shendelman, Ph.D., Founder, Chief Executive Officer and Chair of the Board, will ring the Nasdaq Closing Bell on Tuesday, December 17, 2019, at 4:00 p.m. ET. The ceremony wil...

NEW YORK, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Applied Therapeutics Inc. (Nasdaq:APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the presentation of d...